Zurich Cantonal Bank’s Nuvation Bio NUVB Stock Holding History

Zurich Cantonal Bank’s Portfolio NUVB Stock Details NUVB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$285K	Hold	50,230	–	–	﹤0.01%	2206
2026 Q1	$215K	Buy	+50,230	New	+$280K	﹤0.01%	2225
2025 Q4	–	Sell	-43,050	Closed	-$267K	–	3186
2025 Q3	$159K	Hold	43,050	–	–	﹤0.01%	2276
2025 Q2	$83.9K	Hold	43,050	–	–	﹤0.01%	2401
2025 Q1	$75.8K	Hold	43,050	–	–	﹤0.01%	2465
2024 Q4	$115K	Hold	43,050	–	–	﹤0.01%	2386
2024 Q3	$98.6K	Hold	43,050	–	–	﹤0.01%	2425
2024 Q2	$126K	Buy	+43,050	New	+$131K	﹤0.01%	2278
2023 Q4	–	Sell	-18,409	Closed	-$24.7K	–	2771
2023 Q3	$24.7K	Hold	18,409	–	–	﹤0.01%	2690
2023 Q2	$33.1K	Hold	18,409	–	–	﹤0.01%	2677
2023 Q1	$30.6K	Hold	18,409	–	–	﹤0.01%	2699
2022 Q4	$35.3K	Buy	18,409 +5,072	+38%	+$10.3K	﹤0.01%	2683
2022 Q3	$30K	Hold	13,337	–	–	﹤0.01%	2732
2022 Q2	$43K	Hold	13,337	–	–	﹤0.01%	2642
2022 Q1	$70K	Hold	13,337	–	–	﹤0.01%	2426
2021 Q4	$113K	Hold	13,337	–	–	﹤0.01%	2440
2021 Q3	$133K	Hold	13,337	–	–	﹤0.01%	2168
2021 Q2	$124K	Buy	+13,337	New	+$152K	﹤0.01%	2101

Other funds holding NUVB

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

OFM

Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return

LCM

Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

DFO

Duquesne Family Office New York $5.21B AUM 87.01% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Zurich Cantonal Bank's NUVB Position: Q2 2026 in Review

Zurich Cantonal Bank held its Nuvation Bio (NUVB) position steady in Q2 2026 at 50,230 shares worth $285K. The position accounts for ﹤0.01% of the portfolio, ranked #2206.

Zurich Cantonal Bank first reported a position in NUVB in Q2 2021 and has held it in 18 quarters since. 244 funds tracked by Wall St. Rank hold NUVB as of Q2 2026.

Zurich Cantonal Bank held 50,230 shares of Nuvation Bio worth $285K as of Q2 2026.
Zurich Cantonal Bank left its Nuvation Bio share count unchanged in Q2 2026.
Nuvation Bio made up ﹤0.01% of Zurich Cantonal Bank's portfolio in Q2 2026, its #2206 holding.
Zurich Cantonal Bank first reported a position in Nuvation Bio in Q2 2021 and has held it in 18 quarters since.
244 funds tracked by Wall St. Rank held Nuvation Bio as of Q2 2026.

Based on Zurich Cantonal Bank's 13F filing for Q2 2026, filed 12 Aug 2026.